Pulmonary Immune Cell-microbiome Interactions in ARDS
Recruiting
Observational Study
ARDS, Human
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- Hvidovre University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall aim is to compare the composition and spatial heterogeneity of the following in critically ill intensive care unit (ICU) patients: i) immune cell populations and their activation patterns, ii) the surrounding cytokine-chemokine milieu, including trans-compartmental fluxes of these mediators between the lung and bloodstream, and iii) the lung microbiome.
Main hypotheses:
* The immune …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Inclusion criteria - moderate-to-severe ARDS
* Admitted to the ICU at Hvidovre Hospital
* Intubated within the past 72 hours
* Moderate-to-severe ARDS according to the Berlin definition19
* Age ≥ 18 years
Inclusion criteria - none-to-mild ARDS
* Admitted to the ICU at Hvidov…
Contacts